PubRank

Alma Zernecke

Author PubWeight™ 98.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007 5.28
2 The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008 4.20
3 JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002 3.17
4 Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res 2004 2.68
5 Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007 2.54
6 CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2008 2.52
7 Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab 2010 2.33
8 Role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation 2013 2.18
9 Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009 2.15
10 Neutrophil secretion products pave the way for inflammatory monocytes. Blood 2008 2.12
11 Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2006 1.99
12 Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 2011 1.95
13 Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 2010 1.94
14 Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010 1.86
15 Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med 2011 1.84
16 Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 2012 1.71
17 Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 2010 1.68
18 Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2012 1.64
19 Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005 1.63
20 Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol 2004 1.62
21 Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis. Arterioscler Thromb Vasc Biol 2008 1.58
22 Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 2004 1.51
23 Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 2007 1.49
24 Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. J Am Coll Cardiol 2008 1.43
25 Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment. Proc Natl Acad Sci U S A 2008 1.41
26 CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest 2011 1.39
27 Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 2006 1.31
28 The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood 2008 1.29
29 Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J Exp Med 2008 1.27
30 Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost 2007 1.27
31 Chemokines in vascular remodeling. Thromb Haemost 2007 1.27
32 Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res 2004 1.19
33 Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation 2013 1.18
34 Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 2009 1.17
35 Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol Med 2013 1.15
36 Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2007 1.09
37 A new monocyte chemotactic protein-1/chemokine CC motif ligand-2 competitor limiting neointima formation and myocardial ischemia/reperfusion injury in mice. J Am Coll Cardiol 2010 1.09
38 Chemokines: inflammatory mediators of atherosclerosis. Arch Physiol Biochem 2006 1.08
39 Molecular imaging of inflammation in atherosclerosis. Theranostics 2013 1.08
40 SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? Trends Cardiovasc Med 2006 1.05
41 The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function. Diabetes 2011 1.05
42 Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 2007 1.04
43 C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 2007 1.04
44 Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice. FASEB J 2011 1.00
45 Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood 2006 0.99
46 Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost 2009 0.98
47 Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol 2005 0.98
48 Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report. Arterioscler Thromb Vasc Biol 2009 0.97
49 Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury. Circulation 2010 0.93
50 Macrophages and immune cells in atherosclerosis: recent advances and novel concepts. Basic Res Cardiol 2015 0.93
51 MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism. FASEB J 2010 0.92
52 Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 2005 0.91
53 MCP-1 induces a novel transcription factor with proapoptotic activity. Circ Res 2006 0.89
54 Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Res Cardiol 2005 0.89
55 Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Arterioscler Thromb Vasc Biol 2012 0.88
56 C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 2010 0.88
57 Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke. Arch Immunol Ther Exp (Warsz) 2012 0.87
58 Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig. J Heart Lung Transplant 2009 0.86
59 Plasmacytoid dendritic cells in atherosclerosis. Front Physiol 2012 0.86
60 Dynamic changes in murine vessel geometry assessed by high-resolution magnetic resonance angiography: a 9.4T study. J Magn Reson Imaging 2008 0.85
61 Adult progenitor cells in vascular remodeling during atherosclerosis. Biol Chem 2008 0.85
62 Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012 0.84
63 microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis. J Mol Med (Berl) 2012 0.83
64 CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice. Thromb Haemost 2013 0.83
65 Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction. J Cell Mol Med 2014 0.83
66 Non- invasive in vivo analysis of a murine aortic graft using high resolution ultrasound microimaging. Eur J Radiol 2011 0.82
67 Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-gamma. Eur J Immunol 2004 0.80
68 Caffeine enhances endothelial repair by an AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol 2008 0.79
69 Evaluation of a novel system for hypothermic oxygenated pulsatile perfusion preservation. Int J Artif Organs 2009 0.76
70 The hemostatic system as a regulator of inflammation in atherosclerosis. IUBMB Life 2014 0.76
71 Echogenic perfluorohexane-loaded macrophages adhere in vivo to activated vascular endothelium in mice, an explorative study. Cardiovasc Ultrasound 2015 0.75
72 Noncoding RNAs in vascular inflammation and atherosclerosis: recent advances toward therapeutic applications. Curr Opin Lipidol 2014 0.75
73 Early venous manifestation of Ehlers-Danlos syndrome Type IV through a novel mutation in COL3A1. Cardiovasc Pathol 2013 0.75
74 Thienopyridines in percutaneous coronary interventions: standard procedures and high risk subsets. Curr Pharm Des 2006 0.75
75 Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation. Thromb Haemost 2017 0.75